CD4 and neoplasm: Many of the current studies focus on the tumor-infiltrating lymphocytes (TILs) in the tumor microenvironment, a heterogeneous population including two distinct pools of effector (CD4+ T cells, CD8+ T cells, NK cells) and suppressor (Tregs) phenotypes.